Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950144-05-004448
Filing Date
2005-04-27
Accepted
2005-04-27 17:20:36
Documents
9
Period of Report
2004-12-31

Document Format Files

Seq Description Document Type Size
1 AAIPHARMA INC. g93882ke10vk.htm 10-K 1501178
2 EX-10.4 g93882kexv10w4.htm EX-10.4 8161
3 EX-10.5 g93882kexv10w5.htm EX-10.5 8048
4 EX-10.6 g93882kexv10w6.htm EX-10.6 5397
5 EX-10.7 g93882kexv10w7.htm EX-10.7 8858
6 EX-23 g93882kexv23.htm EX-23 2783
7 EX-31.1 g93882kexv31w1.htm EX-31.1 8396
8 EX-31.2 g93882kexv31w2.htm EX-31.2 8670
9 EX-32 g93882kexv32.htm EX-32 3112
  Complete submission text file 0000950144-05-004448.txt   1556105
Mailing Address 2320 SCIENTIFIC PARK DRIVE WILMINGTON NC 28405
Business Address 2320 SCIENTIFIC PARK DRIVE WILMINGTON NC 28405 9102547000
AAIPHARMA INC (Filer) CIK: 0001013243 (see all company filings)

EIN.: 042687849 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-21185 | Film No.: 05777374
SIC: 8734 Services-Testing Laboratories